Evidence map›Paper›PMID 23438934›Full record

ArticleHypertension (Dallas, Tex. : 1979)2013

Early interference with p44/42 mitogen-activated protein kinase signaling in hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension.

Yang Yu, Bao-Jian Xue, Zhi-Hua Zhang, Shun-Guang Wei, Terry G Beltz, Fang Guo, Alan Kim Johnson, Robert B Felder

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Hypothalamic and inflammatory basis of hypertension.Clinical science (London, England : 1979) · 2017
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Hypothalamic signaling mechanisms in hypertension.Current hypertension reports · 2015
    Review
  20. Mechanisms of brain renin angiotensin system-induced drinking and blood pressure: importance of the subfornical organ.American journal of physiology. Regulatory, integrative and comparative physiology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yang YuDepartment of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242.
Bao-Jian Xue
Zhi-Hua Zhang
Shun-Guang Wei
Terry G Beltz
Fang Guo
Alan Kim Johnson
Robert B Felder
University of Iowa · US

Funding

VASOPRESSIN IN CARDIOVASCULAR REGULATIONP01HL014388 · NHLBI · UNIVERSITY OF IOWA · PI ABBOUD, FRANCOIS M · 1985 to 2018
$40.3M
Cytokines and Sympathetic Activation in Heart FailureR01HL073986 · NHLBI · UNIVERSITY OF IOWA · PI FELDER, ROBERT B · 2003 to 2017
$5.2M
The Stress of Chronic Disease: Mineralocorticoid Mediation of MoodR01MH080241 · NIMH · UNIVERSITY OF IOWA · PI JOHNSON, ALAN KIM · 2010 to 2014
$1.7M
Neural Control of the Circulation: Sex and HypertensionR01HL098207 · NHLBI · UNIVERSITY OF IOWA · PI JOHNSON, ALAN KIM, XUE, BAOJIAN · 2010 to 2013
$1.5M
Brain MAP Kinases - Substrate for Sympathetic Excitation in Heart FailureR01HL096671 · NHLBI · UNIVERSITY OF IOWA · PI FELDER, ROBERT B · 2011 to 2014
$1.5M
NHLBI NIH HHS HL-073986NHLBI NIH HHS HL-096671NHLBI NIH HHS HL-14388NHLBI NIH HHS HL-98207NHLBI NIH HHS P01 HL014388NHLBI NIH HHS R01 HL073986NHLBI NIH HHS R01 HL096671NHLBI NIH HHS R01 HL098207NIMH NIH HHS MH-80241NIMH NIH HHS R01 MH080241
6 · The paper itself

Abstract

Blood-borne angiotensin II (ANG II) can upregulate p44/42 mitogen-activated protein kinase (MAPK) signaling and ANG II type-1 receptors in the hypothalamic paraventricular nucleus (PVN), a critical cardiovascular and autonomic center. We tested the hypothesis that brain p44/42 MAPK signaling contributes to the development of ANG II-induced hypertension. The ANG II infusion (120 ng/kg per min, subcutaneously) induced increases in phosphorylated p44/42 MAPK and ANG II type-1 receptors in the PVN after 1 week, before the onset of hypertension, that were sustained as hypertension developed during a 2- or 3-week infusion protocol. Bilateral PVN microinjections of small interfering RNAs for p44/42 MAPK, at the onset of the ANG II infusion or 1 week later, prevented the early increase in p44/42 MAPK activity. The early treatment normalized ANG II type-1 receptor expression in the PVN and attenuated the hypertensive response to the 2-week infusion of ANG II. The later small interfering RNA microinjections had a transient effect on ANG II type-1 receptor expression in PVN and no effect on the hypertensive response to the 3-week infusion of ANG II. The early treatment also normalized the pressure response to ganglionic blockade. The ANG II infusion induced increases in mRNA for proinflammatory cytokines that were not affected by either small interfering RNA treatment. These results suggest that the full expression of ANG II-induced hypertension depends on p44/42 MAPK-mediated effects. A potential role for p44/42 MAPK in modulating the ANG II-induced central inflammatory response might also be considered. MAPK signaling in PVN may be a novel target for early intervention in the progression of ANG II-dependent hypertension.

Indexed as

Up-RegulationAngiotensin IIAnimalsBlood PressureBlotting, WesternDisease Models, AnimalHypertensionMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Paraventricular Hypothalamic NucleusRatsRats, Sprague-DawleyRNA, MessengerRNA, Small InterferingSignal TransductionAngiotensin IIMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3RNA, MessengerRNA, Small Interfering

Identifiers

PMID23438934
PMCPMC3655907
OpenAlexW2108601636

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.